Ardelyx

Youtube Subscribe

Open: 3.36 Close: 3.33 Change: -0.03

You'll be sorry if you don't use an AI to decide whether to invest in Ardelyx Stock.

The game is changing. There is a new strategy to evaluate Ardelyx fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Ardelyx are: Ardelyx, present, update, Kidney, Week, Ardeylx, past, and the …

Concept Map

Semantic Network

Stock Summary

Cantor Fitzgerald upgraded the previous rating for Ardelyx from Neutral to Overweight. CEO Michael Raab recently sold 11,419 shares in the biotech stock for a total of $40,537.45. Cantor said its upgrade was.

Today's Summary

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at Kidney Week. Ibogaine is the only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or opiate addiction in a single 12-hour session.

Today's News

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at Kidney Week. Ardeylx Inc has fallen 25.16% over the past month, closing at $4.66 on September 14. In the Biotechnology industry, which ranks 136 out of 146 industries, the stock ranks higher than 97%. Shares of Ardelyx (NASDAQ:ARDX) were down more than 12% as of 3:30 p.m. Wednesday afternoon. Ardeylx, inc.s (nasdaq:ardx) institutional investors lost 19% over the past week but have profited from longer-term gains. Ardelyx to present updates for XPHOZAH at Kidney Week 2023 meeting to be held in Philadelphia, PA, November 1-5, 2023. XPHZAH is an investigational first-in-class phosphate absorption inhibitor. Ibogaine is the only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or opiate addiction in a single 12-hour session. Japanese approval triggers $35 million in milestone payments to Ardelyx.

Stock Profile

" Tower Research Capital LLC TRC owned about 0.05% of Ardelyx worth $519,000 as of its most recent filing with the Securities and Exchange Commission (SEC) Bank of New York Mellon Corp raised its holdings by 81.1% during the 1st quarter. Several prominent hedge funds and institutional investors have boosted their stakes in Ardelyx. CEO Michael Raab recently sold 11,419 shares in the biotech stock for a total of $40,537.45. CEO Williams, an important figure within the company, sold 25,000 shares on June 27th. Cantor Fitzgerald has upgraded Ardelyx ( NASDAQ: ARDX ) to overweight in anticipation that the FDA will soon approve its drug Xphozah for the control of serum phosphate levels in dialysis patients. Cantor said its upgrade was based on the potential for Ardeylxs drug Ibsrela to continue to beat expectations. Ardelyx is developing XPHOZAH (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis. The cost of abiliance in Dalasi is 100% in Euros today. Ardelyx, Inc. (NASDAQ: ARDX ) Number of Hedge Fund Holders: 20 Ardeylx,. 20 hedge funds out of the 943 funds in Insider Monkeys database reported owning stakes. Cantor Fitzgerald upgraded the previous rating for Ar delyx from Neutral to Overweight."

Keywords

This document will help you to evaluate Ardelyx without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Ardelyx are: Ardelyx, present, update, Kidney, Week, Ardeylx, past, and the most common words in the summary are: ardelyx, stock, inc, news, ardx, anonymous, tenapanor, . One of the sentences in the summary was: Ibogaine is the only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or opiate addiction in a single 12-hour session.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #ardelyx #stock #inc #news #ardx #anonymous #tenapanor.

Read more →

Youtube Subscribe

---